Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial

Keyphrases

• Adrenal Function 50%
• Between-group 100%
• Block Randomization 25%
• Bone Turnover 50%
• Chronic Rhinosinusitis 50%
• Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) 100%
• Cytokine Levels 25%
• Fluticasone Propionate 50%
• Group Assignment 25%
• Group by 25%
• Hyposmia 50%
• Long-term Efficacy 25%
• Long-term Safety 25%
• Maintenance Therapy 25%
• Mean Group 50%
• Medical Management 25%
• Nasal Drop 25%
• Nasal Inflammation 25%
• Nasal Patency 25%
• Nasal Polyposis 25%
• Nasal Polyps 25%
• Nasal Spray 25%
• Nitric Oxide Level 25%
• Olfaction 25%
• Oral Prednisolone 25%
• Oral Steroids 100%
• Placebo 25%
• Placebo Groups 50%
• Polyp Size 25%
• Polyps 50%
• Prednisolone 50%
• Prednisolone Treatment 25%
• Primary Care 25%
• Primary Care Physicians 25%
• Quality of Life 25%
• Randomized Trial 100%
• Return-to-baseline 25%
• Rhinology 50%
• Scotland 25%
• Serial Measurements 25%
• Single Center 25%
• Specialty Care 50%
• Steroid Maintenance 25%
• Tayside 25%
• Topical Steroid Therapy 50%
• Topical Steroids 100%
• Transient Suppression 25%
• Twice Daily 50%

Medicine and Dentistry

• Adrenal Function 50%
• Bone Turnover 50%
• Chronic Rhinosinusitis 100%
• Cytokine 25%
• Fluticasone Propionate 50%
• Hyposmia 50%
• Maintenance Therapy 25%
• Nasal Polyp 100%
• Nasal Spray 25%
• Nitric Oxide 25%
• Nose Drops 25%
• Olfaction 25%
• Placebo 75%
• Polyp 75%
• Prednisolone 100%
• Primary Health Care 25%
• Quality of Life 25%
• Rhinology 50%
• Steroid Therapy 100%
• Topical Corticosteroid 100%